USPTO serial 79346809
RASTRUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 3, 2023
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RASTRUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachelle A. Dubow, Esq.
Rachelle A. Dubow, Esq. Morgan, Lewis & Bockius LLPOne Federal StreetBoston, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Surgical biological tissue grafts; engineered biological living tissues and 3d cell cultures for medical and surgical use; tissue-regenerative medical preparations for generating skin cells, tissues and organs; biological tissue cultures for medical purposes | ACTIVE | — |
| 009 | Scientific and research apparatus and instruments for use in the fields of life science research, biomedicine and bioprinting, namely, laboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printers, downloadable operating software to control laboratory apparatus for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable software for the purpose of the manufacture of products by means of a 3D printer, including medical products; computer peripherals; laboratory instruments and apparatus, namely cell assembly apparatus for laboratory use for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable electronic publications, namely pamphlets, brochures, journals, books, manuals, newsletters and booklets in the field of biomedical research, 3D printing, cell printing, cell assembly, drug discovery and disease research; recorded and downloadable media, namely audio and video recordings and downloadable audio and video files containing digital matrices and 3-dimensional cell model templates; parts and fittings for all of the foregoing, namely electronic control panels with digital displays for the control of 3D printers, printer cables, and ink cartridges, unfilled, for printers | ACTIVE | — |
| 035 | Data management, namely database management; retail and wholesale store services for pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; administrative processing of purchase orders; computerised procurement services, namely, procurement of pharmaceutical and medical supplies for others, namely ordering and purchasing pharmaceutical and medical supplies for others; computerised data processing; compilation of scientific information into databases; business administration in the nature of maintenance of registers for others, including registers relating to device history and maintenance history | ACTIVE | — |
| 042 | Industrial analysis and research in the field of bioprinting, 3D printing, drug discovery, biomedicine and disease research; industrial design; design and development of computer software; software-as-a-service featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers; platform-as-a-service featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers; providing online non-downloadable software featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers.; computer programming; installation, repair and maintenance of computer software; analysis of statistical data for scientific research; design of software; design of biological materials; design services relating to printing and product design, including design of models and matrices for use in 3-dimensional printing; research relating to design; laboratory research in the field of bioprinting and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers.; technical advisory services relating to scientific products and scientific research; scientific research into the development of new products; engineering services, including hydrogel engineering, and 3D cell culture engineering and tissue engineering; providing technical support services, namely technical advice regarding medical and diagnostic laboratory instruments and systems; providing online non-downloadable web-based software platform for laboratory and diagnostic equipment information management, monitoring and analysis; providing information, including online, about all of the foregoing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Inventia Life Science Pty Ltd
- Other trademarks owned by Inventia Life Science Pty Ltd
- Other trademarks owned by Inventia Life Science Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named RASTRUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 30, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 23, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 8, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 8, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 3, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 3, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 1, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 1, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 1, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 1, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 5, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |